China Drug Maker’s Shares Plunge On AstraZeneca Vaccine “Pause”

Shares in China drug maker Shenzhen Kangtai Biological Products plunged by 16.6% at the Shenzhen Stock Exchange on Wednesday on word that AstraZeneca has temporarily halted testing of a COVID-19 vaccine due to an unexplained illness during its Phase III trial.  (See announcement here.)

Kangtai said last month it signed a licensing pact with AstraZeneca to produce its COVID-19 vaccine AZD1222 in mainland China. Kangtai would annually make at least 100 million doses of the vaccine co-developed with Oxford University by the end of the year, an amount that was expected to rise to at least 200 million doses by the end of 2021, AstraZeneca said, according to a note by S&P Global.

Kangtai, whose products include vaccines, closed at 162.00 yuan. It has declined from an all-time high of $247.66 on August 4.   

Kangtai is led by billionaire entrepreneur Du Weimin. Du, 56, has a fortune worth $4.2 billion on the Forbes Real-Time Billionaires List today. That fortune dropped by $836 million in connection with yesterday’s decline in Kangtai’s shares. His former wife Wang Liping held Kangtai shares worth nearly $4 .6 billion before yesterday’s plunge.

AstraZeneca, a European drug giant considered a global leader in the race to develop a COVID-19 vaccine, has entered into manufacturing agreements elsewhere to ramp up production. 

Among other Chinese companies involved in the vaccine scramble, Shanghai Fosun Pharmaceutical, controlled by billionaire Guo Guangchang, and BioNTech of German said on Aug. 5 that the first 72 participants have already been dosedwith candidate BNT162b1 following approval by Chinese regulatory authority National Medical Products Administration, or NMPA. The trial is part of BioNTech’s global development program.

See related post:

Billionaire Businesswomen Tops List of China’s Richest In Healthcare

@rflannerychina

Speak Your Mind

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get in Touch

350FansLike
100FollowersFollow
281FollowersFollow
150FollowersFollow

Recommend for You

Oh hi there 👋
It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

We don’t spam! Read our privacy policy for more info.

You might also like

Toyota nixes new car, factory plans, blames ‘prohibitive’ tax...

NEW DELHI: Japanese auto major Toyota is suspending plans to launch new cars in...

Daily FX Turnover Drops Nearly 6% To $1.65 Trillion...

LONDON: Daily global currency trading volumes in August fell nearly 6% to $1.659 trillion...

Sensex wipes out early gains to end 98 points...

NEW DELHI: Equity indices wiped out all early gains to finish lower on Monday...

You might be able to rent a Peloton bike...

After a blowout quarter, Peloton is considering ways to make its expensive, high-tech workout equipment more...